Skip to main content
. 2020 Sep 18;20(5):259. doi: 10.3892/ol.2020.12122

Figure 2.

Figure 2.

Construction of a prognostic model using survival-associated, immune-related genes from patients with lung adenocarcinoma. (A) Heatmap of survival-associated immune-related genes in the prognostic model. Distribution of different (B) risk scores and (C) survival status for each patient.